Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.320 | 2 | 169205630 | missense variant | A/G | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Eye Diseases; Male Urogenital Diseases; Nervous System Diseases; Otorhinolaryngologic Diseases | 0.800 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
1.000 | 0.080 | 2 | 169261301 | intron variant | C/T | snv | 0.24 |
|
Immune System Diseases; Nervous System Diseases | 0.710 | 1.000 | 2 | 2017 | 2018 | |||||||
|
2 | 169343942 | intron variant | A/T | snv | 4.6E-02 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | ||||||||||
|
2 | 169154948 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 2 | 2018 | 2019 | |||||||||||
|
2 | 169348613 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 2 | 2019 | 2019 | |||||||||||
|
2 | 169139071 | intron variant | C/T | snv | 4.1E-02 |
|
0.700 | 1.000 | 2 | 2019 | 2019 | ||||||||||
|
2 | 169346323 | intron variant | T/G | snv | 4.6E-02 |
|
0.700 | 1.000 | 2 | 2019 | 2019 | ||||||||||
|
2 | 169151996 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 2 | 2016 | 2019 | |||||||||||
|
1.000 | 0.320 | 2 | 169318886 | splice acceptor variant | T/C | snv | 8.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Eye Diseases; Male Urogenital Diseases; Nervous System Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 2 | 2003 | 2007 | |||||||
|
1.000 | 0.080 | 2 | 169261301 | intron variant | C/T | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
2 | 169188258 | missense variant | G/A | snv | 1.7E-04 | 2.2E-04 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
2 | 169206713 | missense variant | C/T | snv | 2.7E-04 | 4.7E-04 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
2 | 169206713 | missense variant | C/T | snv | 2.7E-04 | 4.7E-04 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
2 | 169197702 | intron variant | G/T | snv | 4.1E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
2 | 169197702 | intron variant | G/T | snv | 4.1E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
2 | 169343942 | intron variant | A/T | snv | 4.6E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
2 | 169343942 | intron variant | A/T | snv | 4.6E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
2 | 169232345 | intron variant | T/C | snv | 3.4E-03 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
2 | 169347589 | intron variant | AA/-;A;AAA;AAAA | delins |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
2 | 169347589 | intron variant | AA/-;A;AAA;AAAA | delins |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
0.925 | 0.120 | 2 | 169237232 | missense variant | C/T | snv | 4.0E-05 | 4.2E-05 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.925 | 0.120 | 2 | 169237232 | missense variant | C/T | snv | 4.0E-05 | 4.2E-05 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.925 | 0.160 | 2 | 169154475 | stop gained | T/A;C | snv | 0.76 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
2 | 169237659 | intron variant | T/C | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
0.925 | 0.080 | 2 | 169348336 | intron variant | C/T | snv | 0.45 |
|
0.700 | 1.000 | 1 | 2010 | 2010 |